Patents by Inventor Christian Ried

Christian Ried has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STABLE AQUEOUS ANTI-TAU ANTIBODY FORMULATIONS
    Publication number: 20210023216
    Abstract: The present disclosure provides stable, aqueous, buffered compositions comprising a high concentration of ABBV-8E12, such as a stable, aqueous buffered composition including ABBV-8E12 at a concentration of about 100 mg/ml, at least one buffer, an excipient, a surfactant, and optionally an antioxidant.
    Type: Application
    Filed: March 22, 2019
    Publication date: January 28, 2021
    Inventors: Jonas ANGSTENBERGER, Kerstin APPENZELLER, Martin HULSMEYER, Katharina KALETA, Tanja MEYER, Christian RIED, Christine RINN, Kathrin SCHAKER-THEOBALD, Michael SIEDLER, Axel WILBERTZ
  • ALBUMIN-MODIFIED NANOPARTICLES CARRYING A TARGETING LIGAND
    Publication number: 20200282075
    Abstract: The present invention relates to cargo substance-loaded, albumin-modified nanoparticles comprising a targeting ligand, to a method for producing such nanoparticles, to nanoparticles obtainable by said method, to a pharmaceutical composition containing a plurality of such nanoparticles and to the medical use of such nanoparticles.
    Type: Application
    Filed: September 6, 2018
    Publication date: September 10, 2020
    Inventors: Lance KALETA, Axel MEYER, Christian RIED, Michael ROHE, Kathrin SCHÄKER-THEOBALD, Sonja TALMON, Christopher UNTUCHT, Tina ZIMMERMANN
  • Phosphoinositide 3-kinases
    Patent number: 6890747
    Abstract: The present invention relates PI3K crystals, polypeptide muteins, polypeptide fragments, antibodies thereto, nucleic acids coding for these polypeptides, methods of modifying PI3K? activity, and methods of modulating PI3K? activity. These include polypeptides and methods thereof, relating to, e.g., phospholipid binding, lipid kinase activity, modulating Ras activity in activating the PI3K?, binding of PI3K? to cell membranes, and modulating protein—protein interactions with PI3K?.
    Type: Grant
    Filed: October 9, 2001
    Date of Patent: May 10, 2005
    Assignees: Warner-Lambert Company, Onyx Pharmaceuticals, Inc.
    Inventors: Roger Williams, Christian Ried, Edward H. Walker, Len Stephens
  • Phosphoinositide 3-kinases
    Publication number: 20030022344
    Abstract: The present invention relates PI3K crystals, polypeptide muteins, polypeptide fragments, antibodies thereto, nucleic acids coding for these polypeptides, methods of modifying PI3K&ggr; activity, and methods of modulating PI3K&ggr; activity. These include polypeptides and methods thereof, relating to, e.g., phospholipid binding, lipid kinase activity, modulating Ras activity in activating the PI3K&ggr;, binding of PI3K&ggr; to cell membranes, and modulating protein-protein interactions with PI3K&ggr;.
    Type: Application
    Filed: October 9, 2001
    Publication date: January 30, 2003
    Inventors: Roger Williams, Christian Ried, Edward H. Walker, Len Stephens